Category: Dentsply International Inc.
Company officials at Dentsply International discuss the company's 3rd quarter 2013 earnings report. Dentsply posted profits of $79.9 million, or 55¢ per share, on sales of $704.0 million for the 3 months ended Sept. 30.
Third-quarter profits for Dentsply surge nearly 50%, but the dental medical device company still misses the earnings mark on acquisition costs.
Dentsply International (NSDQ:XRAY) managed to miss Wall Street's mark for its 3rd-quarter earnings despite a nearly 50% bottom-line surge, as acquisition costs pushed its earnings per share 5¢ under analysts' expectations.
The U.S. Defense Dept. hands Dentsply a contract extension for $13.5 million to cover continued performance testing of surgical products.
The U.S. Defense Dept. awarded a $13.5 million contract extension to the York, Pa.-based Dentsply International (NSDQ:XRAY) for surgical and other medical products.
Second-quarter profits for Dentsply International rose 8% despite flat sales during the period, as market conditions in Europe prompt the medical device company to lower the top end of its 3013 earnings guidance.
Dentsply International (NSDQ:XRAY) managed to boost its 2nd-quarter profits despite flat sales, saying headwinds in Europe will push down its earnings for the rest of the year.
The European Union's 2nd-largest medical device market dips into recession during the 1st 3 months of 2013, meaning more bad news as Europe's economy continues to worsen.
Bad news out of the EuroZone this week as more of the top economies across the pond slipped into a recession, including the European Union's 2nd-largest market for medical devices.
Eurostat, the statistical office of the European Union, said yesterday that the gross domestic product of the 17-nation alliance contracted 0.2% during the first 3 months of 2013 compared to the previous quarter and 1% compared to the same period last year.
Dentsply says earnings in 2013 will be negatively impacted by market conditions in Europe.
Dentsply International (NSDQ:XRAY) boosted profits 35% during the 1st quarter but lowered its 2013 guidance to account for worsening market conditions in the European Union.
Dentsply details its plans to replace ex-CFO William Jellison, who jumped ship ater 15 years for medical device company Stryker.
Dentsply International (NSDQ:XRAY) detailed its plans to replace ex-CFO William Jellison, who jumped ship today for medical device company Stryker (NYSE:SYK).